Subsequently, the Shulin Li team found that circulating tumor cells (CTCs) from patients with prostate and colorectal cancers have higher expressions of nPD-L1, indicating that nuclear localization of PD-L1 may be involved in cancer progression and metastasis, holding a significant prognostic value [144]. This evidence concerns the gene CD274 and colorectal cancer.